Mass drug administration in the Ebola epidemic in Sierra Leone and Liberia
Channel: F1000
Date: 10/06/2015

John Pringle, McGill University, Montreal, Canada talks about how MSF did two mass drug administrations of 3-day courses of artesunate-amodiaquine (ASAQ) as both treatment and chemoprevention for malaria in Freetown, Sierra Leone and Monrovia, Liberia in collaboration with the ministries of health. He discussees how they expected the intervention to significantly reduced the number of febrile patients in the targeted communities and in the holding centers, resulting in a likely decreased risk of transmission of Ebola to malaria patients; and a reduction of “non Ebola” pressure on the health system. In these two contexts, mass distribution of antimalarials proved to be feasible, welcomed by the communities and, despite some reported minor adverse events, relatively well adhered to in terms of dosage.

Slides are available to download here: http://f1000research.com/slides/1000082.

This video is part of an F1000Research channel that includes posters, slides and videos from the MSF Scientific Day meetings in the UK and India. To see more please visit: http://f1000research.com/msf/sciday-uk15.